Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132841) titled 'Development and Application of a PRO-Driven Symptom Management Question-Answering System for Patients with Prostate Cancer Undergoing Androgen Deprivation Therapy' on Sept. 18.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Henan Provincial People's Hospital
Condition:
prostate cancer
Intervention:
Intervention group:Digital health intervention
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: Intervention group:25;Control group:25;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj...